Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 147820-47-1 hbvseq1aa:18-27 in China, also supports custom service. Welcome to wholesale bulk high quality cas 147820-47-1 hbvseq1aa:18-27 from our factory. Contact us for more details.
| Description | HBV sequence-1 residues 18–27, an HLA-restricted CD8+ T epitope; used for HBV-specific CTL responses, viral clearance and therapeutic vaccines. |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| HBV Seq1 aa:18-27 | HBV core antigen 18-27; FLPSDFFPSV; HBcAg 18-27 epitope; hepatitis B CTL epitope; CAS 147820-47-1 | Therapeutic HBV vaccines,CTL epitope identification,Peptide-MHC tetramers,Chronic hepatitis B immunity,HLA-A*0201 | H-Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val-OH; residues 18-27 of the hepatitis B virus core antigen HBcAg (UniProt P03146, genotype D/ayw), a classic HLA-A*0201-restricted CD8+ T-cell epitope; linear peptide with free N-terminal amine / free C-terminal carboxyl; 3 Phe residues give strong hydrophobicity-watch for aggregation after reconstitution. | C58H78N10O15 | 1154.56 | 1155.32 | TFA salt / free acid (per COA) | 10 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-HBV1827-01 | White to off-white powder. | -20°C, dry, sealed, light-protected; avoid repeated freeze-thaw. | 2-8°C, dry and light-protected; use within 2 weeks. | Hydrophobic 10-mer (3×Phe): first dissolve in a small amount of DMSO (5-10 mg/mL stock), then dilute with sterile water/PBS; aromatic hydrophobic segments may aggregate after reconstitution-keep dilute, prepare fresh, store stock in aliquots at -20°C. | powder is stable ~1-2 years at -20°C dry and light-protected. |
Functional Description
| Product Code | Frontend Short Summary | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-HBV1827-01 | HBV core Ag 18-27 HLA-A*0201-restricted 10-mer FLPSDFFPSV for HBV CTL and therapeutic-vaccine research. | HBcAg 18-27 (FLPSDFFPSV) is the immunodominant HLA-A*0201-restricted CD8+ T-cell epitope in HBV infection, recognized by HBV-specific CTLs; a core tool for therapeutic HBV-vaccine development, CTL epitope identification, peptide-MHC tetramers and chronic-HBV immunopathology research. | Therapeutic HBV vaccines,CTL epitope identification,Peptide-MHC tetramers,Chronic hepatitis B immunity | HBcAg epitope presented by HLA-A*0201 (MHC class I); HBV-specific CD8+ T-cell TCR |
Hot Tags: cas 147820-47-1 hbvseq1aa:18-27, China cas 147820-47-1 hbvseq1aa:18-27 manufacturers, suppliers, factory, cateninpeptide, 124454-83-7, 199727-68-9, 265669-37-2, Ac MBP 1 11 , CAS 199727 68 9
